FULL PAPERS
Selective 5-exo-dig Cyclization of in Situ Synthesized N-Boc-2-aminophenyl
1083, 763 cmÀ1; HR-MS (ESI-TOF): m/z=358.1411, calcd.
for C21H21NNaO3 [M+Na]+: 358.1419.
HR-MS
(ESI-TOF):
m/z=389.1112,
calcd.
for
C20H18N2NaO5 [M+Na]+: 389.1113.
tert-Butyl
2-formyl-5-methyl-3-phenyl-1H-indole-1-car-
tert-Butyl 2-formyl-3-(5-methylthiophene-2-yl)-1H-indole-
1-carboxylate (6r): 6r was obtained from 5r (317 mg,
1 mmol) following general procedure C as a yellow-colored
gum; yield: 221 mg (65%); Rf =0.63 (SiO2, 10% EtOAc/
90% hexanes); 1H NMR (400 MHz, CDCl3): d=10.15 (s,
1H), 8.14 (d, J=8.5 Hz, 1H), 7.91 (d, J=7.9 Hz, 1H), 7.51
(t, J=7.9 Hz, 1H), 7.32 (t, J=7.9 Hz, 1H), 7.28 (d, J=
3.4 Hz, 1H), 6.86 (d, J=3.4 Hz, 1H), 2.57 (s, 3H), 1.67 (s,
9H); 13C NMR (75 MHz, CDCl3): d=182.1, 149.7, 142.7,
137.5, 132.5, 130.5, 128.9, 128.7, 128.0, 125.9, 125.7, 123.8,
122.5, 115.2, 85.4, 28.0, 15.4; IR: n=3855, 3694, 1638, 1219,
1096, 772 cmÀ1; HR-MS (ESI-TOF): m/z=364.0992, calcd.
for C19H19NNaO3S [M+Na]+: 364.0983.
boxylate (6m): 6m was obtained from 5m (311 mg, 1 mmol)
following general procedure C as a light yellow solid; yield:
247 mg (74%); mp 110–1128C; Rf =0.68 (SiO2, 10% EtOAc/
90% hexanes); 1H NMR (400 MHz, CDCl3): d=10.08 (s,
1H), 8.04 (d, J=8.5 Hz, 1H), 7.56–7.45 (m, 5H), 7.36–7.33
(m, 2H), 2.41 (s, 3H), 1.68 (s, 9H); 13C NMR (100 MHz,
CDCl3): d=182.6, 149.9, 135.9, 133.4, 132.9, 132.6, 131.2,
130.7, 130.4, 128.5, 128.4, 121.6, 115.0, 85.1, 28.0, 21.3; IR:
n=3855, 3694, 3019, 1626, 1318, 1140, 668 cmÀ1; HR-MS
(ESI-TOF): m/z=358.1409, calcd. for C21H21NNaO3 [M+
Na]+: 358.1419.
tert-Butyl
2-formyl-3-(4-methoxyphenyl)-6-methyl-1H-
indole-1-carboxylate (6n): 6n was obtained from 5n (341 mg,
1 mmol) following general procedure C as a light yellow
solid: yield: 292 mg (80%); mp 115–1178C; Rf =0.50 (SiO2,
20% EtOAc/80% hexanes); 1H NMR (400 MHz, CDCl3):
d=10.07 (s, 1H), 8.03 (d, J=8.6 Hz, 1H), 7.51 (d, J=8.6 Hz,
2H), 7.38 (s, 1H), 7.33 (d, J=8.6 Hz, 1H), 7.03 (d, J=
8.6 Hz, 2H), 3.88 (s, 3H), 2.42 ( s, 3H), 1.68 (s, 9H);
13C NMR (100 MHz, CDCl3): d=182.6, 160.0, 150.0, 135.9,
133.3, 132.9, 132.4, 132.0, 130.3, 128.6, 123.3, 121.7, 115.0,
113.9, 85.0, 55.4, 28.0, 21.3; IR: n=3402, 1731, 1674, 1079,
669 cmÀ1; HR-MS (ESI-TOF): m/z=388.1521, calcd. for
C22H23NNaO4 [M+Na]+: 388.1525.
tert-Butyl 2-formyl-3-vinyl-1H-indole-1-carboxylate (6s):
6s was obtained from 5s (247 mg, 1 mmol) following general
procedure C as a colorless gum; yield: 162 mg (60%); Rf =
1
0.65 (SiO2, 10% EtOAc/90% hexanes); H NMR (400 MHz,
CDCl3): d=10.41 (s, 1H), 8.19 (d, J=8.4 Hz, 1H), 7.95 (d,
J=8.0 Hz, 1H), 7.53–7.49 (m, 1H), 7.34 (t, J=8.0 Hz, 1H),
7.29–7.24 (m, 1H), 6.01 (dd, J=11.6, 1.2 Hz, 1H), 5.69 (dd,
J=11.6, 1.2 Hz, 1H), 1.69 (s, 9H); 13C NMR (75 MHz,
CDCl3): d=184.6, 149.9, 137.3, 132.5, 128.4, 128.2, 127.5,
126.9, 124.0, 122.5, 121.3, 116.0, 85.8, 28.2; IR: n=3855,
3694, 3019, 1524, 1313, 1123, 669 cmÀ1; HR-MS (ESI-TOF):
m/z=294.1116, calcd. for C16H17NNaO3 [M+Na]+: 294.1106.
tert-Butyl 2-formyl-3-(prop-1-en-2-yl)-1H-indole-1-carbox-
ylate (6t): 6t was obtained from 5t (261 mg, 1 mmol) follow-
ing general procedure C as a colorless gum; yield: 193 mg
(68%); Rf =0.60 (SiO2, 10% EtOAc/90% hexanes);
1H NMR (400 MHz, CDCl3): d=10.29 (s, 1H), 8.12 (d, J=
8.5 Hz, 1H), 7.66 (d, J=7.9 Hz, 1H), 7.51–7.47 (m, 1H),
7.29 (t, J=7.9 Hz, 1H), 5.48 (t, J=1.6 Hz, 1H), 5.12 (t, J=
1.6 Hz, 1H), 2.17 (s, 3H), 1.68 (s, 9H); 13C NMR (100 MHz,
CDCl3): d=183.4, 150.0, 137.3, 136.5, 134.6, 132.0, 128.6,
127.9, 123.6, 122.1, 118.5, 115.6, 85.4, 28.2, 23.6; IR: n=3437,
2401, 1674, 1158, 927, 670 cmÀ1; HR-MS (ESI-TOF): m/z=
308.1263, calcd. for C17H19NNaO3 [M+Na]+: 308.1263.
tert-Butyl 2-formyl-5,6-dimethoxy-3-para-tolyl-1H-indole-
1-carboxylate (6o): 6o was obtained from 5o (371 mg,
1 mmol) following general procedure C as a brown solid:
yield: 276 mg (70%); mp 95–978C; Rf =0.54 (SiO2, 20%
1
EtOAc/80% hexanes); H NMR (400 MHz, CDCl3): d=9.93
(s, 1H), 7.71 (s, 1H), 7.45 (d, J=8.0 Hz, 2H), 7.32 (d, J=
8.0 Hz, 2H), 6.94 (s, 1H), 4.01 (s, 3H), 3.85 ( s, 3H), 2.45 (s,
3H), 1.67 (s, 9H); 13C NMR (75 MHz, CDCl3): d=181.5,
151.8, 150.0, 147.6, 138.5, 134.7, 133.3, 131.3, 130.3, 129.2,
128.3, 125.7, 120.7, 102.1, 97.6, 84.8, 56.2, 56.1, 27.9, 21.3;
IR: n=3413, 1731, 1661, 1381, 1224, 850, 667 cmÀ1; HR-MS
(ESI-TOF): m/z=418.1617, calcd. for C23H25NNaO5 [M+
Na]+: 418.1630.
tert-Butyl 2-formyl-5,6-dimethoxy-3-phenyl-1H-indole-1-
carboxylate (6p): 6p was obtained from 5p (357 mg, 1 mmol)
following general procedure C as a brown solid; yield:
259 mg (68%); mp 90–928C; Rf =0.60 (SiO2, 20% EtOAc/
80% hexanes); 1H NMR (400 MHz, CDCl3): d=9.94 (s,
1H), 7.72 (s, 1H), 7.56–7.46 (m, 5H), 6.92 (s, 1H), 4.01 (s,
3H), 3.85 ( s, 3H), 1.67 (s, 9H); 13C NMR (75 MHz, CDCl3):
d=181.6, 151.9, 150.0, 147.7, 134.5, 133.3, 131.5, 131.4, 130.5,
128.6, 128.6, 120.8, 102.0, 97.7, 85.0, 56.3, 56.2, 28.0; IR: n=
3855, 3681, 2400, 1619, 1143, 928, 669 cmÀ1; HR-MS (ESI-
TOF): m/z=404.1463, calcd. for C22H23NNaO5 [M+Na]+:
404.1474.
tert-Butyl 2-formyl-3-(phenylethynyl)-1H-indole-1-carbox-
ylate (6u): 6u was obtained from 5u (321 mg, 1 mmol) fol-
lowing general procedure C as a brown solid; yield: 248 mg
(72%); mp 96–988C; Rf =0.55 (SiO2, 10% EtOAc/90% hex-
1
anes); H NMR (400 MHz, CDCl3): d=10.42 (s, 1H), 8.14
(d, J=8.4 Hz, 1H), 7.89 (d, J=7.9 Hz, 1H), 7.68–7.65 (m,
2H), 7.54 (t, J=7.4 Hz, 1H), 7.40–7.38 (m, 4H), 1.70 (s,
9H); 13C NMR (75 MHz, CDCl3): d=181.8, 149.4, 137.3,
137.1, 132.1, 129.1, 129.0, 128.8, 128.5, 124.1, 122.8, 120.0,
115.8, 113.3, 98.6, 85.9, 80.7, 28.1; IR: n=3402, 3020, 2401,
1733, 1377, 1128, 929 cmÀ1; HR-MS (ESI-TOF): m/z=
368.1258, calcd. for C22H19NNaO3 [M+Na]+: 368.1263.
tert-Butyl 2-formyl-3-(pent-1-ynyl)-1H-indole-1-carboxyl-
ate (6v): 6v was obtained from 5v (287 mg, 1 mmol) follow-
ing general procedure C as a brown solid; yield: 227 mg
(73%); mp 114–1168C; Rf =0.60 (SiO2, 10% EtOAc/90%
hexanes); 1H NMR (400 MHz, CDCl3): d=10.31 (s, 1H),
8.10 (d, J=8.5 Hz, 1H), 7.77 (d, J=7.8 Hz, 1H), 7.50 (t, J=
8.5 Hz, 1H), 7.33 (t, J=7.8 Hz, 1H), 2.55 (t, J=7.0 Hz, 2H),
1.75–1.70 (m, 2H), 1.67 (s, 9H), 1.12 (t, J=7.4 Hz, 3H);
13C NMR (75 MHz, CDCl3): d=181.7, 149.4, 137.2, 137.2,
129.2, 129.0, 123.9, 122.0, 115.6, 114.7, 100.8, 85.6, 71.8, 28.0,
22.2, 22.1, 13.6; IR: n=3787, 3659, 3401, 1526, 1385, 928,
tert-Butyl 2-formyl-5-nitro-3-phenyl-1H-indole-1-carboxyl-
ate (6q): 6q was obtained from 5q (342 mg, 1 mmol) follow-
ing general procedure C as a yellow solid; yield: 311 mg
(85%); mp 225–2278C; Rf =0.60 (SiO2, 20% EtOAc/80%
hexanes); 1H NMR (300 MHz, CDCl3): d=10.10 (s, 1H),
8.52 (d, J=1.9 Hz, 1H), 8.37 (dd, J=9.2, 1.9 Hz, 1H), 8.27
(d, J=9.2 Hz, 1H), 7.64–7.45 (m, 5H), 1.70 (s, 9H);
13C NMR (75 MHz, CDCl3): d=182.1, 149.0, 144.5, 140.1,
134.5, 132.8, 130.6, 129.5, 129.4, 128.9, 128.1, 123.3, 118.7,
115.8, 87.0, 27.9; IR: n=3396, 1742, 1330, 1075, 703 cmÀ1
;
Adv. Synth. Catal. 2014, 356, 1823 – 1834
ꢀ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1831